References
Adachi, K., Takayasu, S. 1972. The mechanism of testosterone action of the sebaceous glands of the Syrian hamster. In: “Advances in Biology of Skin”, vol. XII“Pharmacology and the Skin”, p. 381. Eds : W. Montagna, E. J. van Scott and R. Stoughton. Appleton Century Crofts Educational Division, Meredit Corporation, New York.
Aydinlik, S., Lachnit-Fixson, U. 1977. Diane-eine Gestagen-östrogenkombination mit Antiandrog- enwirkung. Med. Mtonatsschr. 31, 425–429.
Baulieu, E. E., Jung, I. 1970. A prostatic cytosol receptor. Biochem. Biophys. Res. Commun. 38, 599–606.
Beach, F. A., Westbrook, W. H. 1968. Morphological and behavioural effects of an ‘antiandrogen’ in male rats. J. Endocrinol. 42, 379–882.
Belham, J. E., Neal, G. E., Williams, D. 1969 a. The reception of androgens in the rat ventral prostate. Biochem. J. 114, 32P.
Belham, J. E., Neal, G. E., Williams, D. 1969 b. Testosterone metabolism in the rat ventral prostate. Biochim. Biophys. Acta 187, 159–162.
Beyer, J., Demisch, K., Wiegelmann, W., Happ, J., Kollmann, F., Schöffling, 1973. Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty. Acta Endocrinol. (Copenhagen) Suppl. 173, 169.
Bossi, E., Joss, E. E., Zurbrugg, R. P. 1973 a. Evaluation of the effectiveness of treatment on adult height prognosis in disorders with advanced and retarded bone age. Acta Paediat. Scand. 62, 401–404.
Bossi, E., Zurbrügg, R. P. 1973. Behandlung der Pubertas praecox mit dem Antiandrogen Cyproteronacetat. Klin. Wochenschr. 51, 774.
Bossi, E., Zurbrugg, R. P., Joss, E. E. 1973 b. Improvement of adult height prognosis in precocious puberty by cyproterone acetate. Acta Paediat. Scand. 62, 405–412.
Bracci, U., di Silverio, F. 1972. Present procedure with regard to the use of hormone therapy in cases of cancer of the prostate. In: Proceedings of the 18th World Congress Int. College of Surgeons, Rome 1972, pp. 275–276. ICS 29. Eds.: P. Steffanini and V. Speranza. Excerpta Medica, Amsterdam.
Braendle, W., Boess, H., Breckwoldt, M., Leven, Ch., Bettendorf, G. 1974. Wirkung und Nebenwirkung der Cyproteronacetatbehandlung. Arch. Gynaekol. 216, 335–345.
]Dorfman, R. I. 1962. Anti-androgenic substances. In:“Methods in Hormone Research”, vol. II, chapt. 7, pp. 315–323. Ed.: R. I. Dorfman. Academic Press, New York, London.
Dorfman, R. I. 1964. Antiandrogenis, antiestrogenic and antiovulatory compounds. In:“Hormonal Steroids. Biochemistry, Pharmacology and Therapeutics”, vol 1, p. 39–50. Eds.: L. Martini and A. Pecile. Academic Press, New York, London.
Dorfman, R. I. 1970. Biological activity of anti- androgens. Brit. J. Dermatol. 82, Suppl. 6, 3–8.
Ebling, F. J. 1957 a. The action of testosterone and oestradiol on the sebaceous glands and epidermis of the rat. J. Embryol. Exp. Morphol. 5, 74–82.
Ebling, F. J. 1957 b. The action of testosterone on the sebaceous glands and epidermis in castrated and hypophysectomized male rats. J. Endocrinol 15, 297–306.
Ebling, F. J. 1970. Factors influencing the response to the sebaceous glands of the rat to androgen. Brit. J. Dermatol. 82, Suppl. 6, 9–14.
Ebling, F. J. 1973. The effects of cyproterone acetate and oestradiol upon testosterone stimulated sebaceous activity in the rat. Acta Endocrinol. (Copenhagen) 72, 361–365.
Ebling, F. J. 1974. Hormonal control and methods of measuring sebaceous gland activity. J. Invest. Dermatol 62, 161–171.
Ebling, F. J., Skinner, J. 1967. The measurement of sebum production in rats treated with testosterone and oestradiol. Brit. J. Dermatol. 79, 386–393.
EIger, W. 1966. Die Rolle der fetalen Androgene in der Sexualdifferenzierung des Kaninchens und ihre Abgrenzung gegen andere hormonale und somatische Faktoren durch Anwendung eines starken Antiandrogens. Arch. Anat. Microsc. Morphol. Exp. 55, 657–743.
Fang, S., Anderson, K. M., Liao, S. 1969. Receptor proteins for androgens. On the role of specific proteins in selective retention of 17β-hydroxy- 5α-androstan-3-one by rat ventral prostate in vivo and in vitro. J. Biol. Chem. 244, 6584–6595.
Fang, S., Liao, S. 1969. Antagonistic action of antiandrogens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate. Mol. Pharmacol. 5, 428–431.
Fang, S., Liao, S. 1971. Androgen receptors. Steroid- and tissue-specific retention of a 17β-hydroxy-5α-androstan-3-one protein complex by the cell nuclei of ventral prostate. J. Biol. Chem. 246, 16–24.
Geller, J., Baron, A., Fishman, J. 1971. Effects of cyprO’terone acetate on pituitary and gonadal function in elderly males. Clin. Res. 19, 171.
Geller, J., Fruchtman, B., Meyer, C., Newman, H. 1967. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate. J. Clin. Endocrinol. Metab. 27, 556–560.
Geller, J., McCoy, K. 1972. Correlation of biologic and biochemical effects of antiandrogens on rat ventral prostate. Clin. Res. 20, 177.
de Graaf, H. J. 1943. The effect of sex hormones on sebaceous glands. Ned. Tijdschr. Geneesk. 87, 1450.
Graf, K.-J., Brotherton, J., Neumann, F. 1974. Clinical uses of antiandrogens (other than for hyper-sexuality and sexual deviations). In: “Handbook of Experimental Pharmacology”, vol. 35/2, chapt. 7, pp. 485–542. Eds.: O. Eichler, A. Farah, H. Herken and A. D. Welch. Springer-Verlag, Berlin, Heidelberg, New York.
Hamada, H., Neumann, F., Junkmann, K. 1963. Intrauterine antimaskuline Beeinflussung von Rattenfeten durch ein stark gestagen wirksames Steroid. Acta Endocrinol. (Copenhagen) 44, 380–388.
Hammerstein, J., Cupceancu, B. 1969. Behandlung des Hirsutismus mit Cyproteronacetat. Deut. Med. Wochenschr. 94, 829–834.
Haskin, D., Lasher, N., Rothman, S. 1953. Some effects of ACTH, cortisone, progesterone and testosterone on sebaceous glands in white rat. J. Invest. Dermatol. 20, 207–212.
Helige, H. 1973. Fruhreife. Monatsschr. Kinderheilk. 121, 636–646.
Hertel, P., Kramer, M., Neumann, F. 1969. Ein- fluβ eines Antiandrogens (Cyproteronacetat) auf Knochenwachstum und Knochenreifung mannlicher Ratten. Arzneim. Forsch. 19, 1777–1790.
Jacobi, G. H., Senge, Th., Ackermann, R. 1980. Wissenschaftliche Ausstellung Nr. 11, XXXII. Kongress Deutsch. Gesellsch. Urol., Berlin, September 10–13.
Jung, I, Baulieu, E. E. 1971. Neo-nuclear androgen receptor in rat ventral prostate. Biochimie 53, 807–817.
Lapière, C., Chevremont, M. 1953. Modifications des glandes sebacees par des hormones sexuelles appliquees localement sur la peau de Souris. CR. Soc. Biol. 147, 1302–1306.
Lerner, L. J. 1964. Hormone antagonists: inhibitors of specific activities of estrogen and androgen. Recent Progr. Horm. Res. 20, 435–490.
Mauermayer, W. 1971. Cyproterone therapy in prostatic cancer stage IV. In:“International Symposium on the Treatment of Carcinoma of the Prostate”, Berlin 1969, pp. 179–180. (Life Sciences Monographs 1). Eds.: G. Raspé and W. Brosig. Pergamon Press, Vieweg, Oxford, Edinburgh, New York.
Mellin, P. 1971. Cyproterone therapy in prostatic cancer stage IV. In:“International Symposium on the Treatment of Carcinoma of the Prostate”, Berlin 1969, p. 180. (Life Sciences Monographs 1). Ed.: G. Raspé and W. Brosig. Pergamon Press, Vieweg, Oxford, Edinburgh, New York.
Montagna, W., Kenyon, P. 1949. Growth potentials and mitotic division in sebaceous glands of the rabbit. Anat. Ree. 103, 365–379.
Morse, H. C., Leach, D. R., Rowley, M. J., Heller, C. G. 1973. Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men. J. Reprod. Feit. 32, 365–378.
Neumann, F. 1977. Probleme der Dosisfindung: Sexualhormone. Arzneim. Forsch. 27, 296–318.
Neumann, F. 1979. Antiandrogene—Grundlagen und experimentelle Befunde an der Haut. In: “Haar und Haarkrankheiten”, Kapitel 40, S. 961–1009. C. E. Orfanos (Hrsgb.). Gustav Fischer Verlag, Stuttgart, New York.
Neumann, F., von Berswordt-Wallrabe, R., Elger, W., Steinbeck, H., Hahn, J. D., Kramer, M. 1970 a. Aspects of androgen-dependent events as studied by antiandrogens. Laurentian Hormone Conference, Mont Tremblant / Canada 1969. Recent. Progr. Horm. Res. 26, 337–410.
Neumann, F., Diallo, F. A., Hasan, S. H., Schenck, B., Traoré, I. 1976. The influence of pharmaceutical compounds on male fertility. Andrologie 8, 203–235.
Neumann, F., Elger, W., Steinbeck, H. 1970 b. Antiandrogens and reproductive development. Phil. Trans. Roy. Soc. London Ser. B. 259, 179–184.
Neumann, F., Elger, W., Steinbeck, H., von Berswordt-Wallrabe, R. 1967. Antiandrogene. In: “Das Testosteron—die Struma”, pp. 78–101. Ed.: E. Klein. Springer-Verlag, Berlin, Heidelberg, New York.
Neumann, F., Gräf, K.-J., Hasan, S. H., Schenck, B., Steinbeck, H. 1977. Central actions of antiandrogens. In:“Anrogens and Antiandrogens”, pp. 163–177. Eds.: L. Martini and M. Motta, Raven Press, New York.
Neumann, F., Hamada, H. 1964. Intrauterine Feminisierung männlicher Rattenfeten durch das stark gestagen wirksame e-chlor-6-methylen- 17αhydroxy-progesteronacetat. 10. Symposium der Deutschen Gesellschaft fur Endokrinologie, Wien 1963, S. 301–304. Springer-Verlag, Berlin, Heidelberg, New York.
Neumann, F., Steinbeck, H. 1974. Antiandrogens. In:“Handbook of Experimental Pharmacology”, vol. 35/2, chapt. 6, pp. 235–484. Eds.: O. Eichler, A. Farah, H. Herken and A. D. Welch. Springer- Verlag, Berlin, Heidelberg, New York.
Ott, F. 1968. Hypersexualitat, Antiandrogene und Hodenfunktion. Praxis 57, 218–220.
Ott, F. Hoffet, H. 1968. Beeinflussung von Libido, Potenz und Hodenfunktion durch Antiandro- gene. Schweiz. Med. Wochenschr. 98, 1812–1815.
Schenck, B., Neumann, F. 1973. Einfluβ von Sexualhormonen auf Knochenreifung und Knochenwachstum weiblicher Ratten. Arzneim Forsch. 23, 887–907.
Schindler, A. E. 1977. Behandlung mit Antiandrogenen in der Gynakologie Deut. Med. Wochenschr. 102, 763–765.
Scott, W. W. 1971. Cyproterone acetate treatment of disseminated prostatic cancer and benign nodular hyperplasia. In:“International Symposium on the Treatment of Carcinoma of the Prostate”, Berlin 1969, pp. 161–163. (Life Sciences Monographs 1). Eds.: G. Raspé and W. Brosig. Pergamon Press - Vieweg, Oxford, Edinburgh, New York.
Smith, R. B., Walsh, P. C., Goodwin, W. E. 1973. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J. Urol. 110, 106–108.
Steinbeck, H., Neumann, F. 1971. Effect of cyproterone acetate on puberty. J. Reprod. Fert. 26, 59–63.
Trolp, R., Breckwoldt, M., Rachel, F., Braendle, W. 1979. Probleme der Antiandrogenbehand-lung. Gynaekol. Prax. 3, 73–78.
Wein, A. J., Murphy, J. J. 1973. Experience in the treatment of prostatic carcinoma with cyproterone acetate. J. Urol. 109, 68–70.
Wendt, H., Hummelinck, R. 1980. The effect of cyproterone acetate on some endocrinological parameters. In: Androgenization in Women— Acne, Seborrhoen, Androgenetic Alopecia and Hirsutism”, pp. 259–265. Eds.: J. Hammerstein, U. Lachnit-Fixson, F. Neumann and G. Plewig. Excerpta Medica, Amsterdam, Oxford, Princeton.
Wiechert, R., Neumann, F. 1965. Gestagene Wirksamkeit von 1-Methyl- und 1,2α-Methylen- Steroiden. IV. Mitteilung: 1-Methyl-Steroide. Arzneim. Forsch. 15, 244–246.
Author information
Authors and Affiliations
Additional information
This article contains parts of a lecture given as Guest Speaker at a Joint Meeting of the Irish endocrine Society and Endocrine Section of the Royal society of Medicine, held in Dublin, April 2, 1981.
Rights and permissions
About this article
Cite this article
Neumann, F. Pharmacology and clinical use of antiandrogens: A short review. Ir J Med Sci 151, 61–70 (1982). https://doi.org/10.1007/BF02940148
Issue Date:
DOI: https://doi.org/10.1007/BF02940148